Treatment outcome of female agoraphobics 3-9 years after exposure in vivo: a comparison with healthy controls

Autor: Winfried Rohr, Michael Rufer, Iver Hand, Helmut Peter, Eva Brückner
Přispěvatelé: University of Zurich, Peter, H
Rok vydání: 2005
Předmět:
Adult
medicine.medical_specialty
Treatment outcome
Psychological intervention
Implosive Therapy
610 Medicine & health
Experimental and Cognitive Psychology
Severity of Illness Index
2738 Psychiatry and Mental Health
Sex Factors
Arts and Humanities (miscellaneous)
In vivo
International Classification of Diseases
Internal medicine
medicine
Humans
Longitudinal Studies
Psychiatry
Agoraphobia
Aged
Psychiatric Status Rating Scales
Cognitive Behavioral Therapy
3205 Experimental and Cognitive Psychology
Panic disorder
3203 Clinical Psychology
Complete remission
Middle Aged
medicine.disease
Control Groups
Diagnostic and Statistical Manual of Mental Disorders
Psychiatry and Mental health
Clinical Psychology
10057 Klinik für Konsiliarpsychiatrie und Psychosomatik
Treatment Outcome
1201 Arts and Humanities (miscellaneous)
Anxiety
Panic Disorder
Female
medicine.symptom
Psychology
Anxiety disorder
Follow-Up Studies
Zdroj: Journal of behavior therapy and experimental psychiatry. 39(1)
ISSN: 0005-7916
Popis: It is well documented that most agoraphobics, with or without panic disorder, respond to exposure in vivo. But only little data compared their anxiety levels at follow-up (FU) with those of healthy controls. Forty-two female agoraphobics with or without panic disorder participated in FUs 3-9 years after exposure in vivo. Agoraphobic symptoms were compared to data of 42 healthy controls, who were matched according to gender, age, marital and occupational status. Remission criteria were defined from agoraphobia scores of the controls. A total of 17 (40%) of the patients had no further agoraphobic symptoms at all. A total of 15 (36%) patients still had mild-to-moderate agoraphobic symptoms at FU. A total of 10 (24%) were non-responders and suffered from severe agoraphobia at FU. The percentage of treated patients with complete remission is much higher than previously reported. However, the majority still suffer from mild or severe agoraphobic symptoms and could possibly benefit from additional interventions.
Databáze: OpenAIRE
Externí odkaz: